PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Molecular Medicine and Medical Biotechnology, University of Napoli Federico II, Via S. Pansini 5, 80131, Naples, Italy.\', \'Istituto di Endocrinologia e Oncologia Sperimentale, Consiglio Nazionale Delle Ricerche (IEOS-CNR), Naples, Italy.\', \'CEINGE Biotecnologie Avanzate s.c.ar.l., Naples, Italy.\', \'Department of Molecular Medicine and Medical Biotechnology, University of Napoli Federico II, Via S. Pansini 5, 80131, Naples, Italy. tommaso.russo@unina.it.\', \'Department of Molecular Medicine and Medical Biotechnology, University of Napoli Federico II, Via S. Pansini 5, 80131, Naples, Italy. paola.salvatore@unina.it.\', \'CEINGE Biotecnologie Avanzate s.c.ar.l., Naples, Italy. paola.salvatore@unina.it.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s12879-021-06054-2
?:doi
?:hasPublicationType
?:journal
  • BMC infectious diseases
is ?:pmid of
?:pmid
?:pmid
  • 33853532
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.576
?:rankingScore_hIndex
  • 80
is ?:relation_isRelatedTo_publication of
?:title
  • Estimating asymptomatic SARS-CoV-2 infections in a geographic area of low disease incidence.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all